Literature DB >> 11730748

Differentiating clinical profiles: predicting good responders, poor responders, and hyperresponders.

I Kligman1, Z Rosenwaks.   

Abstract

OBJECTIVE: To describe the different clinical and laboratory diagnostic methods (basal and dynamic tests) available to identify poor-, good-, and high-responder patients undergoing treatment with in vitro fertilization (IVF).
DESIGN: Analytical review.
SETTING: IVF program. PATIENTS: Women in different age groups undergoing IVF treatment. INTERVENTION(S): Assessment of clinical and laboratory parameters and correlation with outcomes. MAIN OUTCOME MEASURE(S): Response to ovarian stimulation and success of the assisted reproductive technologies (ART). RESULT(S): Age, basal follicle-stimulating hormone (FSH), estradiol and inhibin-B levels, and dynamic testing serve to predict individual response to ovarian stimulation for ART. CONCLUSION(S): Markers of ovarian reserve (day 3 FSH, inhibin B and E(2)) are particularly predictive and useful in guiding the choice of the optimal protocol for ART. However, no tests are absolutely predictive of a successful outcome. For the younger individual, and for the patient at risk of developing ovarian hyperstimulation syndrome (OHSS), assessment and identification of clinical and laboratory parameters predictive of a high response to ovarian stimulation should guide the clinician in choosing an appropriate stimulation protocol, thus attenuating the risk of OHSS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11730748     DOI: 10.1016/s0015-0282(01)02893-x

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  23 in total

1.  Cycle characteristics of day 3 embryo transfers with 4-cell embryos only.

Authors:  G Ertzeid; R Storeng; T Tanbo; P O Dale; S Bjercke; T Abyholm
Journal:  J Assist Reprod Genet       Date:  2003-09       Impact factor: 3.412

2.  A novel "delayed start" protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders.

Authors:  Hakan Cakmak; Nam D Tran; A Musa Zamah; Marcelle I Cedars; Mitchell P Rosen
Journal:  Fertil Steril       Date:  2014-03-14       Impact factor: 7.329

3.  Predicting pregnancy in women undergoing in-vitro fertilization with basal serum follicle stimulating hormone levels between 10.0 and 11.9 IU/L.

Authors:  Dan Levin; Sunny H Jun; Michael H Dahan
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-03-01

4.  Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF.

Authors:  Shelley Ehrlich; Paige L Williams; Stacey A Missmer; Jodi A Flaws; Xiaoyun Ye; Antonia M Calafat; John C Petrozza; Diane Wright; Russ Hauser
Journal:  Hum Reprod       Date:  2012-09-26       Impact factor: 6.918

5.  Do estrogen receptor alpha polymorphisms have any impact on the outcome in an ART program?

Authors:  Elli Anagnostou; Fotodotis Malamas; Despina Mavrogianni; Vasiliki Dinopoulou; Peter Drakakis; Konstantinos Kallianidis; Dimitris Loutradis
Journal:  J Assist Reprod Genet       Date:  2013-03-15       Impact factor: 3.412

6.  Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles.

Authors:  MaryFran Sowers; Daniel McConnell; Katherine Gast; Huiyong Zheng; Bin Nan; Jenifer D McCarthy; John F Randolph
Journal:  Fertil Steril       Date:  2009-12-06       Impact factor: 7.329

7.  Use of stimulated serum estradiol measurements for the prediction of hyperresponse to ovarian stimulation in in vitro fertilization (IVF).

Authors:  D J Hendriks; E R Klinkert; L F J M M Bancsi; C W N Looman; J D F Habbema; E R te Velde; F J Broekmans
Journal:  J Assist Reprod Genet       Date:  2004-03       Impact factor: 3.412

8.  Estradiol level on day 9 as a predictor of risk for ovarian hyperresponse during controlled ovarian hyperstimulation.

Authors:  Hsin-Yi Ho; Robert Kuo-Kuang Lee; Ming-Huei Lin; Yuh-Ming Hwu
Journal:  J Assist Reprod Genet       Date:  2003-06       Impact factor: 3.412

Review 9.  Different ovarian stimulation protocols for women with diminished ovarian reserve.

Authors:  D Loutradis; P Drakakis; E Vomvolaki; A Antsaklis
Journal:  J Assist Reprod Genet       Date:  2007-11-22       Impact factor: 3.412

10.  Comparison of follicular fluid and serum levels of Inhibin A and Inhibin B with calculated indices used as predictive markers of Ovarian Hyperstimulation Syndrome in IVF patients.

Authors:  Jiri Moos; Karel Rezabek; Vanda Filova; Martina Moosova; Jana Pavelkova; Jana Peknicova
Journal:  Reprod Biol Endocrinol       Date:  2009-08-24       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.